Bal Pharma Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
BALPHARMA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Bal Pharma has submitted a routine compliance certificate to NSE and BSE confirming that details of shares dematerialized and rematerialized during the quarter ended 30 June 2025 were shared with both stock exchanges within the required timeline. The company also confirmed that physical share certificates received for dematerialization were mutilated and cancelled, and the depository's name was updated as the registered owner within 15 days of receipt. MUFG Intime India Pvt Ltd, the company's Registrar and Transfer Agent, issued the underlying certificate. This is a standard procedural filing and contains no business or financial information.
No material impact on shareholders or the stock price. This is a routine regulatory compliance disclosure required of all listed companies and does not signal any change in operations, financials, or corporate action.